Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

22.70p
   
  • Change Today:
      0.60p
  • 52 Week High: 30.60
  • 52 Week Low: 18.00
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 2,890,829
  • Market Cap: £154.44m
  • Beta: 0.29

Latest ShareCast News

hVIVO manufactures human challenge agent for Omicron

By Josh White

Date: Thursday 16 Mar 2023

(Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Thursday.

Open Orphan signs £10.4m contract with global pharma client

By Josh White

Date: Monday 22 Aug 2022

(Sharecast News) - Specialist contract research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £10.4m contract with an existing, unnamed top-five global pharmaceutical client to manufacture a new batch of H1N1 flu challenge virus, and to conduct a human challenge trial to test the client's antiviral product.

Open Orphan wins £7.2m contract for RSV human study

By Josh White

Date: Tuesday 14 Jun 2022

(Sharecast News) - Contract research organisation Open Orphan announced on Tuesday that iits subsidiary hVIVO has signed a £7.2m contract with an existing global pharmaceutical company to test its orally-administered antiviral product using its human challenge study model for respiratory syncytial virus (RSV).

Open Orphan wins £7.3m human flu study contract 18-May-2022 ShareCast
Open Orphan wins £5m contract for human study in... 25-Mar-2022 ShareCast
Open Orphan appoints Mo Khan as its new chief ex... 24-Feb-2022 ShareCast
Open Orphan launches project collecting viral st... 14-Feb-2022 ShareCast
Open Orphan reports on world's first Covid-19 ch... 02-Feb-2022 ShareCast
Open Orphan signs £5m human flu study contract 21-Dec-2021 ShareCast
Open Orphan signs contract to test antiviral can... 10-Dec-2021 ShareCast
Open Orphan subsidiary locks in £5.1m contract w... 17-Nov-2021 ShareCast
Open Orphan subsidiary secures contract renewal ... 15-Nov-2021 ShareCast
Open Orphan signs £5.7m contract with biotech sp... 20-Sep-2021 ShareCast
Open Orphan secures €900,000 contract with... 14-Jul-2021 ShareCast
Open Orphan subsidiary scores 'significant contr... 09-Jul-2021 ShareCast
Cathal Friel-led Poolbeg Pharma set to float on ... 17-Jun-2021 ShareCast
Open Orphan subsidiary signs contract to make Co... 10-May-2021 ShareCast
Open Orphan makes progress with Covid-19 charact... 25-Mar-2021 ShareCast
Open Orphan subsidiary awarded contract with Oxf... 09-Mar-2021 ShareCast
Open Orphan opens new quarantine clinic in White... 03-Feb-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 22.70p
Change Today 0.60p
% Change 2.71 %
52 Week High 30.60
52 Week Low 18.00
Volume 2,890,829
Shares Issued 680.37m
Market Cap £154.44m
Beta 0.29

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.41% below the market average91.41% below the market average91.41% below the market average91.41% below the market average91.41% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Price Trend
46.99% above the market average46.99% above the market average46.99% above the market average46.99% above the market average46.99% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average
Income
90.51% below the market average90.51% below the market average90.51% below the market average90.51% below the market average90.51% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
52.85% above the market average52.85% above the market average52.85% above the market average52.85% above the market average52.85% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 21-Nov-2024

Time Volume / Share Price
15:44 2,728 @ 23.09p
15:38 24,478 @ 22.80p
15:36 5,000 @ 22.95p
15:36 150,000 @ 23.17p
15:32 100,000 @ 23.30p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page